Structure-based design of potent and selective inhibitors targeting RIPK3 for eliminating on-target toxicity in vitro

Journal:

Nature Communications

Published:

2025-05-08

DOI:

10.1038/s41467-025-59432-8

Affiliations:

7

Authors:

12

Go to article

Institutions	Authors	Share
University of Chinese Academy of Sciences (UCAS), China	3.750000	0.31
State Key Laboratory of Drug Research (SKLDR), SIMM CAS, China	2.500000	0.21
University of Chinese Academy of Social Sciences (UCASS), China	2.500000	0.21
Nanjing University of Chinese Medicine (NJUCM), China	1.250000	0.10
University of Nottingham Ningbo China (UNNC), China	1.000000	0.08
Shanghai Synchrotron Radiation Facility (SSRF), SARI CAS, China	1.000000	0.08

Interested in Oncology and Carcinogenesis?